Member Info for MU345

Traders moving from ODX to NCYT today I believe. When ODX release an update they’ll be straight back.

They just go around constantly paying premiums.

I enjoyed buying on the fear this morning... wasn’t even sure what there was to fear. What happens at NCYT has diddly squat to do with ODX.

As MB has pointed out the likelihood of updates prior to the investor presentation is high too.

All good stuff.

“Specimen : Nasopharyngeal swab” - there are likely 100s of nasal swab tests which detect antigen.

It’s not a case of being ‘beaten too it’. The world needs billions upon billions of tests. Though Mologics is saliva anyway and when prepared for commercial distribution towards the end of the year will likely be far more effective in any case .

I hope for the sakes of anyone who has sold on that petty 5% rise there’s no killer RNS in the morning otherwise you’ll be a prize plum.

Won’t be long before this is unleashed into the triple figures territory.

If there’s no update to say the AVCT tie up is ‘fake news’ I’d expect this to finish very strongly today.

I agree. It’s too quiet at the moment. I’m hoping with the increase focus on sales we’ll see some tie ups in the short term.

SP down over 50% since a few months ago. But nothing has changed fundamentally other than perhaps hope that digital glassware would have been more revenue generating in 2020, but as mentioned. I expect that to change soon with this clear focus on sales.

All it needs is a few tie ups providing subscription payments which will hopefully continue to grow over time as the tech becomes more recognised and important. Whilst Infochem providing the core revenue at the moment continues to develop and it’ll see this become a profitable business.

Also worth noting the “implementing the DigitalGlassware™ platform at scale and the launch of new functionality of ICSynth™ in the second half of 2020.”

I see huge potential, especially at this SP. just one of those which may require some patience. Averaged down 5 times now, wouldn’t mind the opportunity to average up at some point lol.

Revenue up 150% to £0.54m.

Losses reduced from £1.62m to £1.17m.

Increased focus on sales with appointment of dedicated sales lead.

Cash balance of just over £4.0m. Circa 3 years cash burn?..

Covid working practices speeding up the recognition and importance for digital glassware. As well as overall development of the industry (Novartis ect).

Presentation outlined a 5 year plan looking to achieve revenues of over £10,000,000 in the future.

So revenue increasing, losses decreasing. Increased focus in sales across all geographies. Previous Infochem acquisition looking positive with strong revenues in last results.

I’ll continue to buy/ average down as it’s clearly already very cheap at circa £14m Mcap, opportunity provided imo by placing and 50,000,000 springer shares. Especially ahead of commercial ramp up and a strong cash position.

IMO.

“The Department of Health and Social Care last week allowed companies to put forward ideas to make 'circa 3.0 million saliva collection kits per day'.”

https://www.dailymail.co.uk/news/article-8777845/Government-use-saliva-based-tests-check-4-5million-people-day.html?ito=push-notification&ci=36318&si=11502321

The Mologic Antigen test is a “lateral flow solution which uses a saliva sample on a test device, which provides a visually read result in 10 minutes.”

Mologic whom have received numerous grants from the ‘Bill & Melinda Gates Foundation and are currently participating in trials at Heathrow airport with their Lft test.

Current rough timelines are that Omega will be commercialising the product in circa 12 weeks time.

At which stage our manufacturing capacity will be well in excess of current with the potential view to increase further in the meantime.

https://mobile.twitter.com/BioDotInc/status/1308182195543011329 - could turn out to be a very important partnership.

“Omega Diagnostics is set for full marketing launch later this month of one of its leading Covid-19 tests following its approval for use in GP surgeries and other professional settings.”

“As things stand, Omega is preparing for initial manufacturing of up to 100,000 of the tests per week at its headquarters in Alva, scaling up to 200,000 tests per week in October. The facility has been undergoing refurbishment to increase its capacity.”

“Mologic is currently applying to have the test listed for “emergency use” by the WHO, which would create further sales outlets.“

https://www.heraldscotland.com/business_hq/18696327.full-launch-later-month-omega-gets-covid-test-approval/

To say we are awaiting several imminent updates on a number of fronts would be a complete understatement.

Fair decision. Pay 80p now or £1+ when we receive orders.

ABC19 - has ‘demand from all 5 continents’
CD4 test - “attracted significant orders and interest from African, Latin American and Asian countries.“

Shares will be in some serious demand on an order RNS.

As per the below which was updated on the 24th, the U.K. government have an antibody test lined up for imminent home use rollout with the option to register interest.

Given the fact they set up a government backed consortium to provide an antibody test for home use which has been in development for over 6 months and is gold standard with 99.40% accurate. As well as all the other signals with updated government guidance, antibodies promoting immunity, Ulster study stating imminent rollout in interviews, significant demand outlined in correspondence by CIGA... I’m probably only scratching the surface.

I expect many will need it written in an RNS though, but obviously that’ll come with a substantial price tag. Hence why those who are well informed know that we’ll be looking back at sub £1 and realise it was absolute bargain territory.

https://www.gov.uk/government/publications/coronavirus-covid-19-antibody-tests/coronavirus-covid-19-antibody-tests

“At-home antibody test kits
This is the start of the UK’s at-home antibody test kit programme.

You can get a free at-home antibody test if all of these apply:

you live in England or Wales
you’re 18 or over
you work in adult social care (England) or domiciliary care (Wales) and get paid”

“Shorts will have a final countdown when £2.5bn rights issue at 60-80% discount is announced”

Yes, I’m sure they’ll raise at 30p.

Haha shorts got burned. Love to see it.

It’s all well and good looking at the SP and guessing that it might be this or that.

But just put the numbers in. 2,000,000 tests per week shortly. Profit margins: Mologic antibody test £1.80 / RTC £0.75 roughly?

+ other elements of the business. Profit should be challenging current market cap and exceeding if there is further expansion, should demand warrant it.

Think we can all agree demand will warrant it.

Nice 5 minute rise back to 0.17 while it lasted.

Think that’s the longest it’s been blue all month.

RTC is gold standard. They sound average at best.

“with most tests reaching a sensitivity value greater than 95 per cent. “

Wouldn’t bother getting out of bed for a test with most having greater than 95% sensitivity.

I took some at 75.00.

Not sure how many more opportunities I’ll have to buy cheap. Too much positive information around.

I bought at 85.00 80.00 77.00 and then again at 72.00 on the way down. Averaging 77 on second position.

With my main holding sitting at 40.00 average.

Tried like mad to buy this morning but couldn’t get a sausage.

Only one way this is going.

Now the 10%ers are our should see this back to mid 80/90s

Yes profit is profit. I just wouldn’t advise checking back in a few weeks down the line.